NLM Logo

ambrisentan MeSH Supplementary Concept Data 2021


MeSH Supplementary
ambrisentan
Unique ID
C467894
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C467894
Entry Term(s)
(+)-(2S)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid
(+)-ambrisentan
(+-)-ambrisentan
(-)-ambrisentan
(R)-ambrisentan
(S)-ambrisentan
BSF 208075
BSF-208075
BSF208075
GSK 1325760
GSK 1325760A
GSK-1325760
GSK-1325760A
GSK1325760
GSK1325760A
LU 208075
LU-208075
LU208075
Letairis
Volibris
ambrisentan, (+-)-
ambrisentan, (-)-
ambrisentan, (R)-
Pharm Action
Antihypertensive Agents
Registry Number
HW6NV07QEC
Related Numbers
177036-94-1
7B43003091
Q1BX7HE63A
Heading Mapped to
*Phenylpropionates
*Pyridazines
Frequency
271
Note
an ET(A) receptor antagonist and antihypertensive agent; studied for use in pulmonary arterial hypertension
Source
Clin Sci (Lond) 2002 Aug;103 Suppl 48:408S-413S
Indexing Information
Hypertension, Pulmonary
Date of Entry
2002/11/15
Revision Date
2021/07/06
ambrisentan Preferred
LU 208075 Narrower
BSF 208075 Narrower
Volibris Narrower
ambrisentan, (-)- Narrower
GSK-1325760 Narrower
Letairis Narrower
ambrisentan, (+-)- Broader
page delivered in 0.007s